What I see in the next few years is that ESC will slowely fade away. Really not much progress is being made there. A lot of money has been spent thou. They will try to recoup some of it I am sure. The real push is going to be towards non evasive ways of collecting stem cells. CBAI seems to be in that arena more and more now. I could see CBAI leaning away from the peripheral blood due to no real way to lower the cost but do see a push towards other means of collecting.
The pace of this is starting to pick up quicker and quicker. Now it is a matter of being in the right position to beable to maximize profits.
A few continents and storage facilities as well as agreements with the two largest Insurance arenas puts CBAI in a better postion then most.
It's been a fun and fruitfull year. I can't wait to see what 2011 will bring. I have my guesses but keeping them to myself for now.
I have to admit it's been fun bumping heads with you thou. Thats how good friends are made.
Market Data 
Markets 
AI
